Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.

Author: AbuTarifMalaz, BhatnagarRahul, ChangYi-Ting, EleyTimothy, GarimellaTushar, LaCretaFrank, MyersElsa, RanaJignasa, SimsKaren, TaoXiaolu, Wind-RotoloMegan

Paper Details 
Original Abstract of the Article :
BACKGROUND: A fixed-dose combination of daclatasvir (DCV; hepatitis C virus NS5A inhibitor), asunaprevir (ASV; non-structural protein 3 inhibitor), and beclabuvir (BCV; non-structural protein 5B inhibitor) is approved in Japan for hepatitis C virus genotype 1. OBJECTIVE: The objective of this study...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833906/

データ提供:米国国立医学図書館(NLM)

Drug-Drug Interactions: Navigating the Complexities of a Pharmaceutical Oasis

This study takes us to a bustling pharmaceutical oasis, where a combination of three drugs—daclatasvir, asunaprevir, and beclabuvir—is used to combat hepatitis C virus (HCV) genotype 1. Imagine this as a carefully curated oasis, offering a variety of potent remedies for those seeking relief from a debilitating disease.

The researchers investigated the potential drug-drug interactions of this combination, employing a cocktail of eight cytochrome P450 (CYP) and transporter probes. This is like carefully testing the compatibility of different ingredients in a potent potion, ensuring they work together harmoniously without causing unforeseen complications.

Interactions and Adjustments: A Balancing Act in the Pharmaceutical Oasis

The study found that the combination did not significantly affect most CYP enzymes but did show moderate induction of CYP2C19 and weak inhibition of CYP3A4, CYP2D6, P-glycoprotein, and organic anion-transporting polypeptide. This is like discovering that some ingredients in the potion may enhance or diminish the effects of others, requiring careful adjustments to ensure optimal effectiveness.

Navigating the Pharmaceutical Oasis: A Need for Caution and Expertise

This study highlights the need for careful consideration of drug-drug interactions when prescribing medications, especially in complex combination therapies. It's like navigating a pharmaceutical oasis with a skilled guide, ensuring that the chosen remedies work in harmony to achieve the desired outcome.

Dr. Camel's Conclusion

This study, like a map guiding travelers through a labyrinth of pharmaceutical possibilities, underscores the importance of understanding drug-drug interactions. It reminds us that the quest for effective treatment often involves a delicate balancing act, requiring careful consideration and expert guidance to ensure the optimal outcome for each individual patient.

Date :
  1. Date Completed 2018-08-27
  2. Date Revised 2021-12-04
Further Info :

Pubmed ID

29255971

DOI: Digital Object Identifier

PMC5833906

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.